Main and moderated effects of multimorbidity and depressive symptoms on cognition.

Braz J Psychiatry

Centro de Integração de Dados e Conhecimentos para Saúde, Fundação Oswaldo Cruz-Fiocruz, Salvador, BA, Brazil. Department of Psychiatry, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.

Published: September 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Multimorbidity, or the occurrence of two or more chronic conditions, is a global challenge, with implications for mortality, morbidity, disability, and life quality. Psychiatric disorders are common among the chronic diseases that affect patients with multimorbidity. It is still not well understood whether psychiatric symptoms, especially depressive symptoms, moderate the effect of multimorbidity on cognition.

Methods: We used a large (n=2,681) dataset to assess whether depressive symptomatology moderates the effect of multimorbidity on cognition using structural equation modelling.

Results: It was found that the more depressive symptoms and chronic conditions, the worse the cognitive performance, and the higher the educational level, the better the cognitive performance. We found a significant but weak (0.009; p = 0.04) moderating effect.

Conclusion: We have provided the first estimate of the moderating effect of depression on the relation between multimorbidity and cognition, which was small. Although this moderation has been implied by many previous studies, it was never previously estimated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851765PMC
http://dx.doi.org/10.47626/1516-4446-2022-2601DOI Listing

Publication Analysis

Top Keywords

depressive symptoms
12
chronic conditions
8
multimorbidity cognition
8
cognitive performance
8
multimorbidity
6
main moderated
4
moderated effects
4
effects multimorbidity
4
depressive
4
multimorbidity depressive
4

Similar Publications

Parkinson's disease patients are at increased risk of road traffic and car accidents and those with excessive daytime sleepiness are specially susceptible. Abnormal scores on the Epworth Sleepiness Scale predicts risk for driving-related somnolence which may cause road traffic accidents in driving patients as many such patients declare dozing of while in a car. Our study estimates that over 40% of patients with daytime somnolence have risks of dozing off in a car.

View Article and Find Full Text PDF

MRI markers of neuroinflammation in untreated patients with subclinical generalized anxiety disorder.

J Neural Transm (Vienna)

September 2025

Sárospatak College, Sztárai Institute, University of Tokaj, Eötvöst str. 7, Sárospatak, 3944, Hungary.

Generalized Anxiety Disorder (GAD) is characterized by excessive worry and physical symptoms of prolonged anxiety. Patients with subclinical GAD-states (sub-GAD) do not fulfill the diagnostic criteria of GAD, but they often show a disease burden similar to GAD, and the subclinical state may turn into a full syndrome. Neuroinflammation may contribute to changes in brain structures in sub-GAD, but direct evidence remains lacking.

View Article and Find Full Text PDF

Glial fibrillary acidic protein (GFAP) is an astrocytic marker that can be assessed in blood using single molecule array technology. Recent studies suggest that individuals with posttraumatic stress disorder (PTSD) have suppressed circulating levels of this CNS biomarker. This study examined the hypothesis that PTSD and plasma GFAP levels share common genetic and epigenetic pathways.

View Article and Find Full Text PDF

This systematic review examined the impact of unemployment and re-employment on mental health problems (depression, anxiety and psychological distress) among working-age adults. We searched MEDLINE, Embase, APA PsycINFO and Web of Science (January 2012-March 2024) and included studies from a prior meta-analysis (1990-2012). Risk of bias was assessed using the Newcastle-Ottawa Scale.

View Article and Find Full Text PDF

Background And Objective: While whole-gland therapies for localized prostate cancer (PCa) offer excellent oncological outcomes, these can impact patients' quality of life (QoL) through serious side effects. Focal therapy using high-intensity focused ultrasound (HIFU) has emerged as a less invasive alternative to preserve QoL. However, data on the psychological impact of HIFU remain rare.

View Article and Find Full Text PDF